Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial

<br><strong>Background<br></strong> Typhoid fever is a major public health problem in low-resource settings. Vaccination can help curb the disease and might reduce transmission. We have previously reported an interim analysis of the efficacy of typhoid conjugate vaccine (TCV)...

詳細記述

書誌詳細
主要な著者:	Shakya, M, Voysey, M, Theiss-Nyland, K, Colin-Jones, R, Pant, D, Adhikari, A, Tonks, S, Mujadidi, YF, O'Reilly, P, Mazur, O, Kelly, S, Liu, X, Maharjan, A, Dahal, A, Haque, N, Pradhan, A, Shrestha, S, Joshi, M, Smith, N, Hill, J, Clarke, J, Stockdale, L, Jones, E, Lubinda, T, Bajracharya, B, Dongol, S, Karkey, A, Baker, S, Dougan, G, Pitzer, VE, Neuzil, KM, Basnyat, B, Pollard, AJ
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2021

Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial

類似資料